Estimating the cost-effectiveness of onabotulinumtoxinA for neurogenic detrusor overactivity in the United States.
Carlson JJ; Hansen RN; Dmochowski RR; Globe DR; Colayco DC; Sullivan SD; Clinical Therapeutics, 2013, vol. 35, issue 4, p 414, ISSN 1879114x. ISBN 1879114x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef